Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma of Lung (Phase 2)
Adrenocortical Carcinoma (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Renal Cell (Phase 1/Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Cholangiocarcinoma (Phase 2)
Gene Amplification (Phase 2)
Heart Diseases (Phase 1)
Leukemia, Myeloid, Acute (Phase 1/Phase 2)
Liposarcoma (Phase 3)
Lymphoma (Phase 1)
Melanoma (Phase 2)
Mesothelioma (Phase 1/Phase 2)
Multiple Myeloma (Phase 1)
Myelodysplastic Syndromes (Phase 1)
Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Pharmacokinetics (Early Phase 1)
Sarcoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Testicular Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue